Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages

  Sergeeva, Irina A ^a   Christoffels, Vincent M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

ANF; BNP; Development; Gene regulation; Heart failure; Natriuretic peptide

Indexed keywords

ADRENALIN; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; FIBROBLAST GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; NATRIURETIC PEPTIDE TYPE C; NORADRENALIN; SOMATOMEDIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR TBX3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BLOOD PRESSURE; BLOOD VOLUME; CARDIOVASCULAR DISEASE; CELL STRESS; CONGESTIVE HEART FAILURE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; HEART AFTERLOAD; HEART DEVELOPMENT; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; IN VIVO STUDY; MECHANICAL STRESS; NATRIURESIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; REVIEW; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE;

ANIMALIA; MAMMALIA;

EID: 84887609004     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.07.003     Document Type: Review

References (176)

1. Kangawa K., Matsuo H. Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem. Biophys. Res. Commun. 1984, 118:131-139.
2. Sudoh T., Kangawa K., Minamino N., Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988, 332:78-81.
3. Steinhelper M.E. Structure, expression, and genomic mapping of the mouse natriuretic peptide type-B gene. Circ. Res. 1993, 72:984-992.
4. Maekawa K., Sudoh T., Furusawa M., Minamino N., Kangawa K., Ohkubo H., Nakanishi S., Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for porcine brain natriuretic peptide. Biochem. Biophys. Res. Commun. 1988, 157:410-416.
5. Greenberg B.D., Bencen G.H., Seilhamer J.J., Lewicki J.A., Fiddes J.C. Nucleotide sequence of the gene encoding human atrial natriuretic factor precursor. Nature 1984, 312:656-658.
6. Tamura N., Ogawa Y., Yasoda A., Itoh H., Saito Y., Nakao K. Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes. J. Mol. Cell. Cardiol. 1996, 28:1811-1815.
7. Nishikimi T., Maeda N., Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc. Res. 2006, 69:318-328.
8. Kishimoto I., Tokudome T., Nakao K., Kangawa K. Natriuretic peptide system: an overview of studies using genetically engineered animal models. FEBS J. 2011, 278:1830-1841.
9. Houweling A.C., van Borren M.M., Moorman A.F.M., Christoffels V.M. Expression and regulation of the atrial natriuretic factor encoding gene Nppa during development and disease. Cardiovasc. Res. 2005, 67:583-593.
10. Cameron V.A., Ellmers L.J. Minireview: natriuretic peptides during development of the fetal heart and circulation. Endocrinology 2003, 144:2191-2194.
11. Bruneau B.G., Nemer G., Schmitt J.P., Charron F., Robitaille L., Caron S., Conner D.A., Gessler M., Nemer M., Seidman C.E., Seidman J.G. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 2001, 106:709-721.
12. Christoffels V.M., Habets P.E.M.H., Franco D., Campione M., de Jong F., Lamers W.H., Bao Z.Z., Palmer S., Biben C., Harvey R.P., Moorman A.F.M. Chamber formation and morphogenesis in the developing mammalian heart. Dev. Biol. 2000, 223:266-278.
13. Habets P.E.M.H., Moorman A.F.M., Clout D.E.W., van Roon M.A., Lingbeek M., Lohuizen M., Campione M., Christoffels V.M. Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation. Genes Dev. 2002, 16:1234-1246.
14. Drazner M.H. The progression of hypertensive heart disease. Circulation 2011, 123:327-334.
15. Vasan R.S., Levy D. The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview. Arch. Intern. Med. 1996, 156:1789-1796.
16. Haider A.W., Larson M.G., Franklin S.S., Levy D. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann. Intern. Med. 2003, 138:10-16.
17. Hellermann J.P., Jacobsen S.J., Gersh B.J., Rodeheffer R.J., Reeder G.S., Roger V.L. Heart failure after myocardial infarction: a review. Am. J. Med. 2002, 113:324-330.
18. Weir R.A., McMurray J.J., Velazquez E.J. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. Am. J. Cardiol. 2006, 97:13F-25F.
19. Bursi F., Enriquez-Sarano M., Jacobsen S.J., Roger V.L. Mitral regurgitation after myocardial infarction: a review. Am. J. Med. 2006, 119:103-112.
20. Schoen F.J. Cardiac valves and valvular pathology: update on function, disease, repair, and replacement. Cardiovasc. Pathol. 2005, 14:189-194.
21. Bekeredjian R., Grayburn P.A. Valvular heart disease: aortic regurgitation. Circulation 2005, 112:125-134.
22. Morita H., Seidman J., Seidman C.E. Genetic causes of human heart failure. J. Clin. Invest. 2005, 115:518-526.
23. Liew C.C., Dzau V.J. Molecular genetics and genomics of heart failure. Nat. Rev. Genet. 2004, 5:811-825.
24. Maron B.J., Maron M.S. Hypertrophic cardiomyopathy. Lancet 2013, 381:242-255.
25. Battistoni A., Rubattu S., Volpe M. Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases. Int. J. Cardiol. 2012, 157:160-168.
26. Feldman A.M., Weinberg E.O., Ray P.E., Lorell B.H. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ. Res. 1993, 73:184-192.
27. Rajabi M., Kassiotis C., Razeghi P., Taegtmeyer H. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail. Rev. 2007, 12:331-343.
28. Knowlton K.U., Rockman H.A., Itani M., Vovan A., Seidman C.E., Chien K.R. Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium. J. Clin. Invest. 1995, 96:1311-1318.
29. Horsthuis T., Houweling A.C., Habets P.E.M.H., de Lange F.J., el Azzouzi H., Clout D.E.W., Moorman A.F.M., Christoffels V.M. Distinct regulation of developmental and heart disease induced atrial natriuretic factor expression by two separate distal sequence. Circ. Res. 2008, 102:849-859.
30. de Bold A.J., Borenstein H.B., Veress A.T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981, 28:89-94.
31. Bianchi C., Gutkowska J., Thibault G., Garcia R., Genest J., Cantin M. Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry 1985, 82:441-452.
32. Jacobowitz D.M., Skofitsch G., Keiser H.R., Eskay R.L., Zamir N. Evidence for the existence of atrial natriuretic factor-containing neurons in the rat brain. Neuroendocrinology 1985, 40:92-94.
33. Tanaka I., Misono K.S., Inagami T. Atrial natriuretic factor in rat hypothalamus, atria and plasma: determination by specific radioimmunoassay. Biochem. Biophys. Res. Commun. 1984, 124:663-668.
34. Ueda S., Sudoh T., Fukuda K., Kangawa K., Minamino N., Matsuo H. Identification of alpha atrial natriuretic peptide [4-28] and [5-28] in porcine brain. Biochem. Biophys. Res. Commun. 1987, 149:1055-1062.
35. Gutkowska J., Antunes-Rodrigues J., McCann S.M. Atrial natriuretic peptide in brain and pituitary gland. Physiol. Rev. 1997, 77:465-515.
36. Arden K.C., Viars C.S., Weiss S., Argentin S., Nemer M. Localization of the human B-type natriuretic peptide precursor (NPPB) gene to chromosome 1p36. Genomics 1995, 26:385-389.
37. Huang H., John S.W., Steinhelper M.E. Organization of the mouse cardiac natriuretic peptide locus encoding BNP and ANP. J. Mol. Cell. Cardiol. 1996, 28:1823-1828.
38. Zeller R., Bloch K.D., Williams B.S., Arceci R.J., Seidman C.E. Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis. Genes Dev. 1987, 1:693-698.
39. Christoffels V.M., Smits G.J., Kispert A., Moorman A.F. Development of the pacemaker tissues of the heart. Circ. Res. 2010, 106:240-254.
40. Gardner D.G., Hedges B.K., Wu J., LaPointe M.C., Deschepper C.F. Expression of the atrial natriuretic peptide gene in human fetal heart. J. Clin. Endocrinol. Metab. 1989, 69:729-737.
41. Johnson D.D., Tetzke T.A., Cheung C.Y. Gene expression of atrial natriuretic factor in ovine fetal heart during development. J. Soc. Gynecol. Investig. 1994, 1:14-18.
42. Mercadier J.J., Zongazo M.A., Wisnewsky C., Butler-Brown G., Gros D., Carayon A., Schwartz K. Atrial natriuretic factor messenger ribonucleic acid and peptide in the human heart during ontogenic development. Biochem. Biophys. Res. Commun. 1989, 159:777-782.
43. Nemer M., Lavigne J.P., Drouin J., Thibault G., Gannon M., Antakly T. Expression of atrial natriuretic factor gene in heart ventricular tissue. Peptides 1986, 7:1147-1152.
44. Moorman A.F.M., Christoffels V.M. Cardiac chamber formation: development, genes and evolution. Physiol. Rev. 2003, 83:1223-1267.
45. Small E.M., Krieg P.A. Expression of atrial natriuretic factor (ANF) during Xenopus cardiac development. Dev. Genes Evol. 2000, 210:638-640.
46. Jensen B., Boukens B.J., Postma A.V., Gunst Q.D., van den Hoff M.J., Moorman A.F., Wang T., Christoffels V.M. Identifying the evolutionary building blocks of the cardiac conduction system. PLoS One 2012, 7:e44231.
47. Houweling A.C., Somi S., Massink M.P.G., Groenen M.A., Moorman A.F.M., Christoffels V.M. Comparative analysis of the natriuretic peptide precursor gene cluster in vertebrates reveals loss of ANF and retention of CNP-3 in chicken. Dev. Dyn. 2005, 233:1076-1082.
48. Cameron V.A., Aitken G.D., Ellmers L.J., Kennedy M.A., Espiner E.A. The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology 1996, 137:817-824.
49. Takahashi T., Allen P.D., Izumo S. Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Circ. Res. 1992, 71:9-17.
50. Pucci A., Wharton J., Arbustini E., Grasso M., Diegoli M., Needleman P., Vigant M., Moscoso G., Polak J.M. Localization of brain and atrial natriuretic peptide in human and porcine heart. Int. J. Cardiol. 1992, 34:237-247.
51. Cantin M., Thibault G., Haile-Meskel H., Ding J., Milne R.W., Ballak M., Charbonneau C., Nemer M., Drouin J., Garcia R., Genest J. Atrial natriuretic factor in the impulse conduction system of rat cardiac ventricles. Cell Tissue Res. 1989, 256:309-325.
52. Hansson M., Forsgren S. Immunoreactive atrial and brain natriuretic peptides are co-localized in Purkinje fibres but not in the innervation of the bovine heart conduction system. Histochem. J. 1995, 27:222-230.
53. Wharton J., Anderson R.H., Springall D., Power R.F., Rose M., Smith A., Espejo R., Khagani A., Wallwork J., Yacoub M.H., Polak J.M. Localization of atrial natriuretic peptide immunoreactivity in the ventricular myocardium and conduction system of the human fetal and adult heart. Br. Heart J. 1988, 60:267-274.
54. Inoue K., Naruse K., Yamagami S., Mitani H., Suzuki N., Takei Y. Four functionally distinct C-type natriuretic peptides found in fish reveal evolutionary history of the natriuretic peptide system. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10079-10084.
55. Snedecor G.W., Cochran W.G. Statistical Methods, Statistical Methods 1982, 274-276. Iowa State University Press, Ames.
56. Kalra P.R., Clague J.R., Bolger A.P., Anker S.D., Poole-Wilson P.A., Struthers A.D., Coats A.J. Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation 2003, 107:571-573.
57. Del R.S., Cabiati M., Vozzi F., Battolla B., Caselli C., Forini F., Segnani C., Prescimone T., Giannessi D., Mattii L. Expression of C-type natriuretic peptide and its receptor NPR-B in cardiomyocytes. Peptides 2011, 32:1713-1718.
58. Thibault G., Charbonneau C., Bilodeau J., Schiffrin E.L., Garcia R. Rat brain natriuretic peptide is localized in atrial granules and released into the circulation. Am. J. Physiol. 1992, 263:R301-R309.
59. Shimoike H., Iwai N., Kinoshita M. Differential regulation of natriuretic peptide genes in infarcted rat hearts. Clin. Exp. Pharmacol. Physiol. 1997, 24:23-30.
60. Hama N., Itoh H., Shirakami G., Nakagawa O., Suga S., Ogawa Y., Masuda I., Nakanishi K., Yoshimasa T., Hashimoto Y. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995, 92:1558-1564.
61. Hori Y., Sano N., Kanai K., Hoshi F., Itoh N., Higuchi S. Acute cardiac volume load-related changes in plasma atrial natriuretic peptide and N-terminal pro-B-type natriuretic peptide concentrations in healthy dogs. Vet. J. 2010, 185:317-321.
62. Marttila M., Vuolteenaho O., Ganten D., Nakao K., Ruskoaho H. Synthesis and secretion of natriuretic peptides in the hypertensive TGR(mREN-2)27 transgenic rat. Hypertension 1996, 28:995-1004.
63. de Bold A.J., Bruneau B.G., Kuroski de Bold M.L. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc. Res. 1996, 31:7-18.
64. Leskinen H., Vuolteenaho O., Leppaluoto J., Ruskoaho H. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release. Endocrinology 1995, 136:1241-1249.
65. Mantymaa P., Vuolteenaho O., Marttila M., Ruskoaho H. Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro. Endocrinology 1993, 133:1470-1473.
66. Bruneau B.G., de Bold A.J. Selective changes in natriuretic peptide and early response gene expression in isolated rat atria following stimulation by stretch or endothelin-1. Cardiovasc. Res. 1994, 28:1519-1525.
67. Kinnunen P., Vuolteenaho O., Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology 1993, 132:1961-1970.
68. Thibault G., Amiri F., Garcia R. Regulation of natriuretic peptide secretion by the heart. Annu. Rev. Physiol. 1999, 61:193-217.
69. Ruskoaho H., Kinnunen P., Taskinen T., Vuolteenaho O., Leppaluoto J., Takala T.E. Regulation of ventricular atrial natriuretic peptide release in hypertrophied rat myocardium. Effects of exercise. Circulation 1989, 80:390-400.
70. Agnoletti G., Cornacchiari A., Panzali A.F., Ghielmi S., De G.F., Ferrari R. Effect of congestive heart failure on rate of atrial natriuretic factor release in response to stretch and isoprenaline. Cardiovasc. Res. 1990, 24:938-945.
71. Bayat H., Swaney J.S., Ander A.N., Dalton N., Kennedy B.P., Hammond H.K., Roth D.M. Progressive heart failure after myocardial infarction in mice. Basic Res. Cardiol. 2002, 97:206-213.
72. Cameron V.A., Rademaker M.T., Ellmers L.J., Espiner E.A., Nicholls M.G., Richards A.M. Atrial (ANP) and brain natriuretic peptide (BNP) expression after myocardial infarction in sheep: ANP is synthesized by fibroblasts infiltrating the infarct. Endocrinology 2000, 141:4690-4697.
73. Kaiser M., Kahr O., Shimada Y., Smith P., Kelly M., Mahadeva H., Adams M., Lodwick D., Aalkjaer C., Avkiran M., Samani N.J. Differential regulation of ventricular adrenomedullin and atrial natriuretic peptide gene expression in pressure and volume overload in the rat. Clin. Sci. (Lond.) 1998, 94:359-365.
74. Franco V., Chen Y.F., Oparil S., Feng J.A., Wang D., Hage F., Perry G. Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling. Hypertension 2004, 44:746-750.
75. Spruill L.S., Baicu C.F., Zile M.R., McDermott P.J. Selective translation of mRNAs in the left ventricular myocardium of the mouse in response to acute pressure overload. J. Mol. Cell. Cardiol. 2008, 44:69-75.
76. Koitabashi N., Arai M., Niwano K., Watanabe A., Endoh M., Suguta M., Yokoyama T., Tada H., Toyama T., Adachi H., Naito S., Oshima S., Nishida T., Kubota S., Takigawa M., Kurabayashi M. Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Eur. J. Heart Fail. 2008, 10:373-379.
77. Zhang Y., Carreras D., de Bold A.J. Discoordinate re-expression of cardiac fetal genes in N(omega)-nitro-L-arginine methyl ester (L-NAME) hypertension. Cardiovasc. Res. 2003, 57:158-167.
78. Dzimiri N., Moorji A., Afrane B., Al-Halees Z. Differential regulation of atrial and brain natriuretic peptides and its implications for the management of left ventricular volume overload. Eur. J. Clin. Invest. 2002, 32:563-569.
79. Ocampo C., Ingram P., Ilbawi M., Arcilla R., Gupta M. Revisiting the surgical creation of volume load by aorto-caval shunt in rats. Mol. Cell. Biochem. 2003, 251:139-143.
80. Lear W., Boer P.H. Rapid activation of the type B versus type A natriuretic factor gene by aortocaval shunt induced cardiac volume overload. Cardiovasc. Res. 1995, 29:676-681.
81. Hutchinson K.R., Guggilam A., Cismowski M.J., Galantowicz M.L., West T.A., Stewart J.A., Zhang X., Lord K.C., Lucchesi P.A. Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure. J. Appl. Physiol. 2011, 111:1778-1788.
82. Brown L.A., Nunez D.J., Wilkins M.R. Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat. J. Clin. Invest. 1993, 92:2702-2712.
83. Kuroski de Bold M.L. Atrial natriuretic factor and brain natriuretic peptide gene expression in the spontaneous hypertensive rat during postnatal development. Am. J. Hypertens. 1998, 11:1006-1018.
84. Kawakami H., Okayama H., Hamada M., Hiwada K. Alteration of atrial natriuretic peptide and brain natriuretic peptide gene expression associated with progression and regression of cardiac hypertrophy in renovascular hypertensive rats. Clin. Sci. (Lond.) 1996, 90:197-204.
85. Sakata Y., Yamamoto K., Masuyama T., Mano T., Nishikawa N., Kuzuya T., Miwa T., Hori M. Ventricular production of natriuretic peptides and ventricular structural remodeling in hypertensive heart failure. J. Hypertens. 2001, 19:1905-1912.
86. Wolf K., Kurtz A., Pfeifer M., Hocherl K., Riegger G.A., Kramer B.K. Different regulation of left ventricular ANP, BNP and adrenomedullin mRNA in the two-kidney, one-clip model of renovascular hypertension. Pflugers Arch. 2001, 442:212-217.
87. Yoshimura M., Yasue H., Tanaka H., Kikuta K., Sumida H., Kato H., Jougasaki M., Nakao K. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure. Br. Heart J. 1994, 72:528-533.
88. Suzuki E., Hirata Y., Kohmoto O., Sugimoto T., Hayakawa H., Matsuoka H., Sugimoto T., Kojima M., Kangawa K., Minamino N. Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells. Circ. Res. 1992, 71:1039-1048.
89. Lekanne Deprez R.H., van den Hoff M.J.B., de Boer P.A.J., Ruijter J.M., Maas A.A.W., Chamuleau R.A.F.M., Lamers W.H., Moorman A.F.M. Changing patterns of gene expression in the pulmonary trunk-banded rat heart. J. Mol. Cell. Cardiol. 1998, 30:1877-1888.
90. Langenickel T., Pagel I., Hohnel K., Dietz R., Willenbrock R. Differential regulation of cardiac ANP and BNP mRNA in different stages of experimental heart failure. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H1500-H1506.
91. Su X., Brower G., Janicki J.S., Chen Y.F., Oparil S., Dell'Italia L.J. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat. J. Mol. Cell. Cardiol. 1999, 31:1927-1936.
92. Walther T., Stepan H., Faber R. Dual natriuretic peptide response to volume load in the fetal circulation. Cardiovasc. Res. 2001, 49:817-819.
93. Yamada J., Fujimori K., Ishida T., Sanpei M., Honda S., Sato A. Plasma endothelin-1 and atrial natriuretic peptide levels during prolonged (24-h) non-acidemic hypoxemia in fetal goats. J. Matern. Fetal Med. 2001, 10:409-413.
94. Zhou C., Zhuang J., Zhang X., Zhang J. Changes in atrial natriuretic peptide levels during cardiac bypass in the fetal goat. Artif. Organs 2008, 32:956-961.
95. Ville Y., Proudler A., Abbas A., Nicolaides K. Atrial natriuretic factor concentration in normal, growth-retarded, anemic, and hydropic fetuses. Am. J. Obstet. Gynecol. 1994, 171:777-783.
96. Scott N.J., Ellmers L.J., Lainchbury J.G., Maeda N., Smithies O., Richards A.M., Cameron V.A. Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development. Biochim. Biophys. Acta 2009, 1792:1175-1184.
97. Potter L.R., Abbey-Hosch S., Dickey D.M. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr. Rev. 2006, 27:47-72.
98. Kimura K., Yamaguchi Y., Horii M., Kawata H., Yamamoto H., Uemura S., Saito Y. ANP is cleared much faster than BNP in patients with congestive heart failure. Eur. J. Clin. Pharmacol. 2007, 63:699-702.
99. Emdin M., Passino C., Prontera C., Fontana M., Poletti R., Gabutti A., Mammini C., Giannoni A., Zyw L., Zucchelli G., Clerico A. Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure. Clin. Chem. 2007, 53:1289-1297.
100. Mueller T., Gegenhuber A., Dieplinger B., Poelz W., Haltmayer M. Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples. Clin. Chem. Lab. Med. 2004, 42:942-944.
101. Gegenhuber A., Struck J., Poelz W., Pacher R., Morgenthaler N.G., Bergmann A., Haltmayer M., Mueller T. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP. Clin. Chem. 2006, 52:827-831.
102. Eindhoven J.A., van den Bosch A.E., Jansen P.R., Boersma E., Roos-Hesselink J.W. The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review. J. Am. Coll. Cardiol. 2012, 60:2140-2149.
103. Beleigoli A., Diniz M., Nunes M., Barbosa M., Fernandes S., Abreu M., Ribeiro A. Reduced brain natriuretic peptide levels in class III obesity: the role of metabolic and cardiovascular factors. Obes. Facts 2011, 4:427-432.
104. Bartels E.D., Nielsen J.M., Bisgaard L.S., Goetze J.P., Nielsen L.B. Decreased expression of natriuretic peptides associated with lipid accumulation in cardiac ventricle of obese mice. Endocrinology 2010, 151:5218-5225.
105. Clerico A., Giannoni A., Vittorini S., Emdin M. The paradox of low BNP levels in obesity. Heart Fail. Rev. 2012, 17:81-96.
106. Magnusson M., Jujic A., Hedblad B., Engstrom G., Persson M., Struck J., Morgenthaler N.G., Nilsson P., Newton-Cheh C., Wang T.J., Melander O. Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study. J. Clin. Endocrinol. Metab. 2012, 97:638-645.
107. A.M.de, Lupon J., Galan A., Vila J., Urrutia A., Bayes-Genis A. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure. Am. Heart J. 2012, 163:821-828.
108. Gluba A., Bielecka A., Mikhailidis D.P., Wong N.D., Franklin S.S., Rysz J., Banach M. An update on biomarkers of heart failure in hypertensive patients. J. Hypertens. 2012, 30:1681-1689.
109. Ahmad T., Fiuzat M., Felker G.M., O'Connor C. Novel biomarkers in chronic heart failure. Nat. Rev. Cardiol. 2012, 9:347-359.
110. Pikkarainen S., Tokola H., Majalahti-Palviainen T., Kerkela R., Hautala N., Bhalla S.S., Charron F., Nemer M., Vuolteenaho O., Ruskoaho H. GATA-4 is a nuclear mediator of mechanical stretch-activated hypertrophic program. J. Biol. Chem. 2003, 278:23807-23816.
111. Kerkela R., Ilves M., Pikkarainen S., Tokola H., Ronkainen V.P., Majalahti T., Leppaluoto J., Vuolteenaho O., Ruskoaho H. Key roles of endothelin-1 and p38 MAPK in the regulation of atrial stretch response. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300:R140-R149.
112. Liang F., Gardner D.G. Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism. J. Clin. Invest. 1999, 104:1603-1612.
113. Liang F., Lu S., Gardner D.G. Endothelin-dependent and -independent components of strain-activated brain natriuretic peptide gene transcription require extracellular signal regulated kinase and p38 mitogen-activated protein kinase. Hypertension 2000, 35:188-192.
114. Aikawa R., Nagai T., Kudoh S., Zou Y., Tanaka M., Tamura M., Akazawa H., Takano H., Nagai R., Komuro I. Integrins play a critical role in mechanical stress-induced p38 MAPK activation. Hypertension 2002, 39:233-238.
115. Liang F., Gardner D.G. Autocrine/paracrine determinants of strain-activated brain natriuretic peptide gene expression in cultured cardiac myocytes. J. Biol. Chem. 1998, 273:14612-14619.
116. Nadruz W., Corat M.A., Marin T.M., Guimaraes Pereira G.A., Franchini K.G. Focal adhesion kinase mediates MEF2 and c-Jun activation by stretch: role in the activation of the cardiac hypertrophic genetic program. Cardiovasc. Res. 2005, 68:87-97.
117. Peng X., Wu X., Druso J.E., Wei H., Park A.Y., Kraus M.S., Alcaraz A., Chen J., Chien S., Cerione R.A., Guan J.L. Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6638-6643.
118. Torsoni A.S., Constancio S.S., Nadruz W., Hanks S.K., Franchini K.G. Focal adhesion kinase is activated and mediates the early hypertrophic response to stretch in cardiac myocytes. Circ. Res. 2003, 93:140-147.
119. Hautala N., Tokola H., Luodonpaa M., Puhakka J., Romppanen H., Vuolteenaho O., Ruskoaho H. Pressure overload increases GATA4 binding activity via endothelin-1. Circulation 2001, 103:730-735.
120. Marttila M., Hautala N., Paradis P., Toth M., Vuolteenaho O., Nemer M., Ruskoaho H. GATA4 mediates activation of the B-type natriuretic peptide gene expression in response to hemodynamic stress. Endocrinology 2001, 142:4693-4700.
121. Lim J.Y., Park S.J., Hwang H.Y., Park E.J., Nam J.H., Kim J., Park S.I. TGF-beta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation. J. Mol. Cell. Cardiol. 2005, 39:627-636.
122. Matsumoto-Ida M., Takimoto Y., Aoyama T., Akao M., Takeda T., Kita T. Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H709-H715.
123. Koivisto E., Kaikkonen L., Tokola H., Pikkarainen S., Aro J., Pennanen H., Karvonen T., Rysa J., Kerkela R., Ruskoaho H. Distinct regulation of B-type natriuretic peptide transcription by p38 MAPK isoforms. Mol. Cell. Endocrinol. 2011, 338:18-27.
124. Harder B.A., Schaub M.C., Eppenberger H.M., Eppenberger-Eberhardt M. Influence of fibroblast growth factor (bFGF) and insulin-like growth factor (IGF-I) on cytoskeletal and contractile structures and on atrial natriuretic factor (ANF) expression in adult rat ventricular cardiomyocytes in culture. J. Mol. Cell. Cardiol. 1996, 28:19-31.
125. Scharin T.M., Redfors B., Lindbom M., Svensson J., Ramunddal T., Ohlsson C., Shao Y., Omerovic E. Importance of circulating IGF-1 for normal cardiac morphology, function and post infarction remodeling. Growth Horm. IGF Res. 2012, 22:206-211.
126. Welch S., Plank D., Witt S., Glascock B., Schaefer E., Chimenti S., Andreoli A.M., Limana F., Leri A., Kajstura J., Anversa P., Sussman M.A. Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ. Res. 2002, 90:641-648.
127. Eppenberger-Eberhardt M., Aigner S., Donath M.Y., Kurer V., Walther P., Zuppinger C., Schaub M.C., Eppenberger H.M. IGF-I and bFGF differentially influence atrial natriuretic factor and alpha-smooth muscle actin expression in cultured atrial compared to ventricular adult rat cardiomyocytes. J. Mol. Cell. Cardiol. 1997, 29:2027-2039.
128. Donath M.Y., Gosteli-Peter M.A., Hauri C., Froesch E.R., Zapf J. Insulin-like growth factor-I stimulates myofibrillar genes and modulates atrial natriuretic factor mRNA in rat heart. Eur. J. Endocrinol. 1997, 137:309-315.
129. Musaro A., McCullagh K.J., Naya F.J., Olson E.N., Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 1999, 400:581-585.
130. Miyashita T., Takeishi Y., Takahashi H., Kato S., Kubota I., Tomoike H. Role of calcineurin in insulin-like growth factor-1-induced hypertrophy of cultured adult rat ventricular myocytes. Jpn. Circ. J. 2001, 65:815-819.
131. Munoz J.P., Collao A., Chiong M., Maldonado C., Adasme T., Carrasco L., Ocaranza P., Bravo R., Gonzalez L., Diaz-Araya G., Hidalgo C., Lavandero S. The transcription factor MEF2C mediates cardiomyocyte hypertrophy induced by IGF-1 signaling. Biochem. Biophys. Res. Commun. 2009, 388:155-160.
132. Luodonpaa M., Vuolteenaho O., Eskelinen S., Ruskoaho H. Effects of adrenomedullin on hypertrophic responses induced by angiotensin II, endothelin-1 and phenylephrine. Peptides 2001, 22:1859-1866.
133. Byrne J.A., Grieve D.J., Bendall J.K., Li J.M., Gove C., Lambeth J.D., Cave A.C., Shah A.M. Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ. Res. 2003, 93:802-805.
134. Mehta P.K., Griendling K.K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell Physiol. 2007, 292:C82-C97.
135. Oro C., Qian H., Thomas W.G. Type 1 angiotensin receptor pharmacology: signaling beyond G proteins. Pharmacol. Ther. 2007, 113:210-226.
136. Ludwig M., Steinhoff G., Li J. The regenerative potential of angiotensin AT2 receptor in cardiac repair. Can. J. Physiol. Pharmacol. 2012, 90:287-293.
137. Senbonmatsu T., Ichihara S., Price E., Gaffney F.A., Inagami T. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J. Clin. Invest. 2000, 106:R25-R29.
138. Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc. Res. 2004, 63:423-432.
139. Majalahti T., Suo-Palosaari M., Sarman B., Hautala N., Pikkarainen S., Tokola H., Vuolteenaho O., Wang J., Paradis P., Nemer M., Ruskoaho H. Cardiac BNP gene activation by angiotensin II in vivo. Mol. Cell. Endocrinol. 2007, 273:59-67.
140. Cheng T.H., Cheng P.Y., Shih N.L., Chen I.B., Wang D.L., Chen J.J. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J. Am. Coll. Cardiol. 2003, 42:1845-1854.
141. Lu Y.M., Shioda N., Han F., Kamata A., Shirasaki Y., Qin Z.H., Fukunaga K. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities. Cardiovasc. Ther. 2009, 27:17-27.
142. Bingham A.J., Ooi L., Kozera L., White E., Wood I.C. The repressor element 1-silencing transcription factor regulates heart-specific gene expression using multiple chromatin-modifying complexes. Mol. Cell. Biol. 2007, 27:4082-4092.
143. Kuwahara K., Saito Y., Ogawa E., Takahashi N., Nakagawa Y., Naruse Y., Harada M., Hamanaka I., Izumi T., Miyamoto Y., Kishimoto I., Kawakami R., Nakanishi M., Mori N., Nakao K. The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. Mol. Cell. Biol. 2001, 21:2085-2097.
144. Glenn D.J., Wang F., Chen S., Nishimoto M., Gardner D.G. Endothelin-stimulated human B-type natriuretic peptide gene expression is mediated by Yin Yang 1 in association with histone deacetylase 2. Hypertension 2009, 53:549-555.
145. Morin S., Paradis P., Aries A., Nemer M. Serum response factor-GATA ternary complex required for nuclear signaling by a G-protein-coupled receptor. Mol. Cell. Biol. 2001, 21:1036-1044.
146. Yoshida Y., Morimoto T., Takaya T., Kawamura T., Sunagawa Y., Wada H., Fujita M., Shimatsu A., Kita T., Hasegawa K. Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes. Circ. J. 2010, 74:156-162.
147. Morisco C., Zebrowski D.C., Vatner D.E., Vatner S.F., Sadoshima J. β-adrenergic cardiac hypertrophy is mediated primarily by the β1-subtype in the rat heart. J. Mol. Cell. Cardiol. 2001, 33:561-573.
148. Barry S.P., Davidson S.M., Townsend P.A. Molecular regulation of cardiac hypertrophy. Int. J. Biochem. Cell Biol. 2008, 40:2023-2039.
149. Vidal M., Wieland T., Lohse M.J., Lorenz K. Beta-adrenergic receptor stimulation causes cardiac hypertrophy via a Gbetagamma/Erk-dependent pathway. Cardiovasc. Res. 2012, 96:255-264.
150. Patrizio M., Vago V., Musumeci M., Fecchi K., Sposi N.M., Mattei E., Catalano L., Stati T., Marano G. cAMP-mediated beta-adrenergic signaling negatively regulates Gq-coupled receptor-mediated fetal gene response in cardiomyocytes. J. Mol. Cell. Cardiol. 2008, 45:761-769.
151. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., Grant S.R., Olson E.N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93:215-228.
152. Zou Y., Yamazaki T., Nakagawa K., Yamada H., Iriguchi N., Toko H., Takano H., Akazawa H., Nagai R., Komuro I. Continuous blockade of L-type Ca2+ channels suppresses activation of calcineurin and development of cardiac hypertrophy in spontaneously hypertensive rats. Hypertens. Res. 2002, 25:117-124.
153. Ohba T., Watanabe H., Murakami M., Takahashi Y., Iino K., Kuromitsu S., Mori Y., Ono K., Iijima T., Ito H. Upregulation of TRPC1 in the development of cardiac hypertrophy. J. Mol. Cell. Cardiol. 2007, 42:498-507.
154. Dulce R.A., Hurtado C., Ennis I.L., Garciarena C.D., Alvarez M.C., Caldiz C., Pierce G.N., Portiansky E.L., Chiappe de Cingolani G.E., Camilion de Hurtado M.C. Endothelin-1 induced hypertrophic effect in neonatal rat cardiomyocytes: involvement of Na+/H+and Na+/Ca2+ exchangers. J. Mol. Cell. Cardiol. 2006, 41:807-815.
155. Diniz G.P., Carneiro-Ramos M.S., Barreto-Chaves M.L. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway. Basic Res. Cardiol. 2009, 104:653-667.
156. Diniz G.P., Carneiro-Ramos M.S., Barreto-Chaves M.L. Thyroid hormone increases TGF-beta1 in cardiomyocytes cultures independently of angiotensin ii type 1 and type 2 receptors. Int. J. Endocrinol. 2010, 2010:384890.
157. Harrelson Z., Kelly R.G., Goldin S.N., Gibson-Brown J.J., Bollag R.J., Silver L.M., Papaioannou V.E. Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development. Development 2004, 131:5041-5052.
158. Aanhaanen W.T., Brons J.F., Dominguez J.N., Rana M.S., Norden J., Airik R., Wakker V., de Gier-de Vries C., Brown N.A., Kispert A., Moorman A.F., Christoffels V.M. The Tbx2+ primary myocardium of the atrioventricular canal forms the atrioventricular node and the base of the left ventricle. Circ. Res. 2009, 104:1267.
159. Warren S.A., Terada R., Briggs L.E., Cole-Jeffrey C.T., Chien W.M., Seki T., Weinberg E.O., Yang T.P., Chin M.T., Bungert J., Kasahara H. Differential role of Nkx2-5 in activation of the ANF gene in developing vs. failing heart. Mol. Cell. Biol. 2011, 31:4633-4645.
160. He Q., Wang D., Yang X.P., Carretero O.A., LaPointe M.C. Inducible regulation of human brain natriuretic peptide promoter in transgenic mice. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H368-H376.
161. Mayer B., Kaiser T., Kempt P., Cornelius T., Holmer S.R., Schunkert H. Molecular cloning and functional characterization of the upstream rat atrial natriuretic peptide promoter. J. Hypertens. 2002, 20:219-228.
162. von Harsdorf R., Edwards J.G., Shen Y.T., Kudej R.K., Dietz R., Leinwand L.A., Nadal-Ginard B., Vatner S.F. Identification of a cis-acting regulatory element conferring inducibility of the atrial natriuretic factor gene in acute pressure overload. J. Clin. Invest. 1997, 100:1294-1304.
163. Small E.M., Krieg P.A. Transgenic analysis of the atrialnatriuretic factor (ANF) promoter: Nkx2-5 and GATA-4 binding sites are required for atrial specific expression of ANF. Dev. Biol. 2003, 261:116-131.
164. Seidman C.E., Schmidt E.V., Seidman J.G. cis-Dominance of rat atrial natriuretic factor gene regulatory sequences in transgenic mice. Can. J. Physiol. Pharmacol. 1991, 69:1486-1492.
165. Field L.J. Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science 1988, 239:1029-1033.
166. Rockman H.A., Ross R.S., Harris A.N., Knowlton K.U., Steinhelper M.E., Field L.J., Ross J., Chien K.R. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:8277-8281.
167. Knowlton K.U., Baracchini E., Ross R.S., Harris A.N., Henderson S.A., Evans S.M., Glembotski C.C., Chien K.R. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during alpha-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression. J. Biol. Chem. 1991, 266:7759-7768.
168. Gomez-Skarmeta J.L., Modolell J. Iroquois genes: genomic organization and function in vertebrate neural development. Curr. Opin. Genet. Dev. 2002, 12:403-408.
169. Houweling A.C., Dildrop R., Peters T., Mummenhoff J., Moorman A.F.M., R ther U., Christoffels V.M. Gene and cluster-specific expression of the Iroquois family members during mouse development. Mech. Dev. 2001, 107:169-174.
170. Tena J.J., Alonso M.E., Calle-Mustienes E., Splinter E., L.W.de, Manzanares M., Gomez-Skarmeta J.L. An evolutionarily conserved three-dimensional structure in the vertebrate Irx clusters facilitates enhancer sharing and coregulation. Nat. Commun. 2011, 2:310.
171. Morkin E. Control of cardiac myosin heavy chain gene expression. Microsc. Res. Tech. 2000, 50:522-531.
172. R.E.van, Quiat D., Johnson B.A., Sutherland L.B., Qi X., Richardson J.A., Kelm R.J., Olson E.N. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell 2009, 17:662-673.
173. van den Boogaard M., Wong L.Y., Tessadori F., Bakker M.L., dreizehnter L.K., Wakker V., Bezzina C.R., 't Hoen P.A., Bakkers J., Barnett P., Christoffels V.M. Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer. J. Clin. Invest. 2012, 122:2519-2530.
174. He A., Kong S.W., Ma Q., Pu W.T. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:5632-5637.
175. Stamatoyannopoulos J.A., Snyder M., Hardison R., Ren B., Gingeras T., Gilbert D.M., Groudine M., Bender M., Kaul R., Canfield T., Giste E., Johnson A., Zhang M., Balasundaram G., Byron R., Roach V., Sabo P.J., Sandstrom R., Stehling A.S., Thurman R.E., Weissman S.M., Cayting P., Hariharan M., Lian J., Cheng Y., Landt S.G., Ma Z., Wold B.J., Dekker J., Crawford G.E., Keller C.A., Wu W., Morrissey C., Kumar S.A., Mishra T., Jain D., Byrska-Bishop M., Blankenberg D., Lajoie1 B.R., Jain G., Sanyal A., Chen K.B., Denas O., Taylor J., Blobel G.A., Weiss M.J., Pimkin M., Deng W., Marinov G.K., Williams B.A., Fisher-Aylor K.I., Desalvo G., Kiralusha A., Trout D., Amrhein H., Mortazavi A., Edsall L., McCleary D., Kuan S., Shen Y., Yue F., Ye Z., Davis C.A., Zaleski C., Jha S., Xue C., Dobin A., Lin W., Fastuca M., Wang H., Guigo R., Djebali S., Lagarde J., Ryba T., Sasaki T., Malladi V.S., Cline M.S., Kirkup V.M., Learned K., Rosenbloom K.R., Kent W.J., Feingold E.A., Good P.J., Pazin M., Lowdon R.F., Adams L.B. An encyclopedia of mouse DNA elements (mouse ENCODE). Genome Biol. 2012, 13:418.
176. Del Greco M.F., Pattaro C., Luchner A., Pichler I., Winkler T., Hicks A.A., Fuchsberger C., Franke A., Melville S.A., Peters A., Wichmann H.E., Schreiber S., Heid I.M., Krawczak M., Minelli C., Wiedermann C.J., Pramstaller P.P. Genome-wide association analysis and fine mapping of NT-proBNP level provide novel insight into the role of the MTHFR-CLCN6-NPPA-NPPB gene cluster. Hum. Mol. Genet. 2011, 20:1660-1671.